Ketamine rescheduling consultation
This consultation seeks your views on the Advisory Council on the Misuse of Drugs’ (ACMD) recommendation to reschedule ketamine to Schedule 2 to the Misuse of Drugs Regulations 2001 (as amended) (the 2001 Regulations).
This follows reclassification under the Misuse of Drugs Act 1971 (the 1971 Act) as a Class B drug on 10 June 2014.
More specifically on the record keeping, prescribing and safe custody requirements applicable to Schedule 2 drugs. Ketamine is currently a Schedule 4 Part 1 drug and therefore lightly regulated. These proposals have been prepared in discussion with the ACMD and the Department of Health.
How to respondYou can respond online.
Alternatively you can send your answers to these questions, together with any other comments, by email to have your say no later than Monday 3 November 2014.
If you prefer you can post your responses to:
Ketamine Consultation
Drug Legislation Team, Drugs and Alcohol Unit
5th Floor (NE)
Fry Building
Home Office
2 Marsham Street
LONDON
SW1P 4DF